• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,180.72 -104.35
( -0.13%)
Global Indices
Nasdaq
52,927.94 -148.97
(-0.28%)
Dow Jones
7,522.05 -36.38
(-0.48%)
Hang Seng
68,399.59 -1,338.10
(-1.92%)
Nikkei 225
10,685.41 33.64
(0.32%)
Forex
USD-INR
95.19 -0.09
(-0.09%)
EUR-INR
108.86 0.10
(0.10%)
GBP-INR
127.02 0.03
(0.03%)
JPY-INR
0.59 0.00
(-0.02%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
132.2958859
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
44.84
40706.58
EPS(TTM)
Face Value()
Div & Yield %
53.59
10
2.37
 

As on: Jul 07, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
2,402.90 2.30 4333 44.84
Stock Price Details
Open Price() 2,417.55
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 2,417.55
Today's Low () 2,388.70
52-Week High () 3356
152-Week Low () 2088
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 2.37
Eps 53.59
Book Value 132.2958859
Market Cap (.Cr) 40,706.58
Face Value 10
Market Lot 1
AGM Date Jun
Book Closure Date
ISIN No. INE159A01016


News
Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter
GSK Pharma gains as Q4 PAT rises 6% YoY to Rs 275 cr
GlaxoSmithKline Pharmaceuticals to hold AGM
Board of GlaxoSmithKline Pharmaceuticals recommends Final Dividend
Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
GSK Pharma Q4 PAT rises 6% YoY to Rs 275 cr
GlaxoSmithKline Pharmaceuticals to announce Quarterly Result
Glaxosmithkline appoints Vinay Subramanian as Commercial Head – Oncology
Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter
More
Corporate Details
Incoporation Year   : 1924
Chairman : Renu S. Karnad
Bussiness Group : MNC Asc-Glaxo
Registered Office
Glaxosmithkline Pharmaceuticals Ltd
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-022-24959595
Fax:91-022-24959494
Fax:91-22-66317458
E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com
URL : http://www.gsk-india.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Midcap
  • CNX 500
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi